Areas of further research
Studies on the development and utilization of scientific guidelines is limited. In light of the speed of innovation and technology further research is needed to identify optimal formats of stakeholder inclusion, to understand the impact on research and development and approval of new therapeutics and vaccines as well as to characterize the role of the regulatory framework on the overall innovation system in the pharmaceutical sector.